Key facts
- IVIRMA Global’s last known valuation is $3.2B (Jan 2023).
- It has raised $2.6B; the latest was PE Growth/Expansion in Feb 2026.
- Notable investors include Abu Dhabi Capital Group, Kohlberg Kravis Roberts.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for IVIRMA Global
- ·The full record, as it builds
Funding rounds
No funding rounds for IVIRMA Global are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IVIRMA Global
Operator of a chain of fertility clinics intended to develop reproductive medicine. The company offers assisted reproduction and related services including artificial insemination, in-vitro fertilization (IVF), egg donation, fertility techniques and testing, sperm donation and embryo scope, allowing couples to turn their dreams of parenthood into reality.
- Sector
- Healthcare
- HQ
- Valencia, Spain
- Founded
- 1990
- Employees
- 6,000
- Website
- ivirma.com/
- Ownership
- Privately Held (backing)
IVIRMA Global doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IVIRMA Global shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IVIRMA Global in its N-PORT filings yet. We sweep new filings monthly.